ʻO nā pono o ka paclitaxel paʻa i ka Albumin

ʻO Paclitaxel kekahi o nā lāʻau lapaʻau lapaʻau maʻamau ʻekolu hanauna, akā ʻilihune kona wai hoʻoheheʻe ʻia a pono e hoʻoheheʻe ʻia me nā solvents organik. pale wale i ka hopena hypersensitivity / toxicity i hoʻokumu ʻia e nā mea hoʻoheheʻe organik, akā ʻaʻole pono ka hoʻomaʻamaʻa ʻana i ka hormone; Hiki iā ia ke lawe i ka albumin i ka paclitaxel mai ke kahe koko ʻoi aku ka wikiwiki, e hele i loko o nā cell endothelial ma o ka receptor mediated endocytosis, a hoʻonui hou i nā ʻiʻo tumora. ma o ka permeability kiʻekiʻe a me ka hopena paʻa (ka hopena EPR) o nā ʻōpū, e hoʻomau nei e hōʻike i nā pono pharmacokinetic.

I ka wā o ka immunotherapy, ʻaʻole lawa ka maikaʻi o ka lāʻau lapaʻau hoʻokahi, a ʻaʻole i ʻoi aku ka nui o ke kala kala (ORR) o ka lāʻau hoʻokahi ma mua o 20%; Pehea e hoʻonui ai i ka poʻe pōmaikaʻi o ka immunotherapy, hui pū ʻia ka hopena maikaʻi, i waena o ia. ʻO ke ʻano o ka chemotherapy hui ka wahi wela o ka ʻimi ʻana i kēia manawa.

Mai kēia hiʻohiʻona, loaʻa i ka paclitaxel paʻa i ka albumin kona mau pono ponoʻī, ʻoi aku ka kiʻekiʻe o kona ORR, hiki iā ia ke pepehi i nā cell tumor i ʻoi aku ka maikaʻi, a hoʻoikaika i ka ʻike ʻana o ka antigen tumor; nā kiko maʻamau.

'Ōlelo Aʻo: ʻO ka pono a me nā noi i hoʻokomo ʻia ma kēia ʻatikala mai nā palapala i paʻi ʻia.

He loea ʻo Yunnan Hande Biotechnology Co., Ltd i ka hana ʻana oAPI paclitaxelʻoi aku ma mua o 20 mau makahiki, a ʻo ia kekahi o nā mea hana kūʻokoʻa o ka honua i ka paclitaxel API, kahi lāʻau anti-cancer i loaʻa i ka mea kanu, apono ʻia e ka US FDA, European EDQM, Australia TGA, Kina CFDA, India, Iapana a me nā ʻoihana hoʻoponopono aupuni ʻē aʻe. .Hiki iā Hande ke hāʻawi ʻaʻole wale ke kūlana kiʻekiʻepaclitaxel maka, akā, ʻo nā lawelawe hoʻomaikaʻi ʻenehana e pili ana i ka paclitaxel formulation. No ka ʻike hou aku, e ʻoluʻolu e kelepona mai iā mākou ma 18187887160.